Nisa Investment Advisors’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
HWAM
SAM
PC
FISPB
Nisa Investment Advisors's OLMA Position: Q2 2026 in Review
Nisa Investment Advisors reduced its Olema Pharmaceuticals (OLMA) stake by 33% in Q2 2026, selling an estimated $25.9K and leaving 3,934 shares worth $49.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.
Nisa Investment Advisors first reported a position in OLMA in Q1 2022 and has held it in 11 quarters since. The position peaked at $134K in Q1 2022. 47 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.
- Nisa Investment Advisors held 3,934 shares of Olema Pharmaceuticals worth $49.2K as of Q2 2026.
- Nisa Investment Advisors sold 1,930 Olema Pharmaceuticals shares in Q2 2026, an estimated $25.9K.
- Olema Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1862 holding.
- Nisa Investment Advisors first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
- Nisa Investment Advisors's Olema Pharmaceuticals position peaked at $134K in Q1 2022.
- 47 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.